Hyderabad, Nov. 4 -- Aurobindo Pharma Limited on Wednesday reported a 32.5 per cent year-on-year increase in consolidated net profit to Rs 1,124 crore for the second quarter ended September 30, 2026, compared to Rs 848 crore in the corresponding quarter last fiscal.
The company's revenue from operations rose 23.9 per cent to Rs 10,263 crore from Rs 8,286 crore in the year-ago period, marking its highest-ever quarterly revenue.
EBITDA, before forex and other income, increased 28.5 per cent to Rs 2,156 crore, while the EBITDA margin improved to 21 per cent from 20.3 per cent in the corresponding quarter last year, Hyderabad based pharma said in a release here.
Revenue from the US market grew 25 per cent year-on-year to Rs 4,555 crore, whil...